Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid
M. John Chapman, José Luís Zamorano, Klaus G. Parhofer
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108172-108172
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Associations of remnant cholesterol with cardiovascular and cancer mortality in a nationwide cohort
Yuan Tian, Yi‐Long Wu, Minjie Qi, et al.
Science Bulletin (2023) Vol. 69, Iss. 4, pp. 526-534
Open Access | Times Cited: 26
Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol
Zhiyuan Wu, Jinqi Wang, Haiping Zhang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Oxidative stress–mediated neuroinflammation in Alzheimer’s disease
Sayed Mohammed Firdous, Sahabaj Ali Khan, Amritangshu Maity
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 15
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table
François Mach, Frank L.J. Visseren, Nilo B. Cater, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 5, pp. e685-e700
Closed Access | Times Cited: 9
Advances in secondary prevention mechanisms of macrovascular complications in type 2 diabetes mellitus patients: a comprehensive review
Huifang Guan, Jiaxing Tian, Ying Wang, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7
Separate and Joint Associations of Remnant Cholesterol Accumulation and Variability With Carotid Atherosclerosis: A Prospective Cohort Study
Jinqi Wang, Rui Jin, Xiaohan Jin, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 14
Open Access | Times Cited: 12
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy
Marja‐Riitta Taskinen, Niina Matikainen, Elias Björnson, et al.
Diabetologia (2023) Vol. 66, Iss. 12, pp. 2307-2319
Open Access | Times Cited: 12
Temporal and Spatial Metabolic Shifts Revealing the Transition from Ulcerative Colitis to Colitis‐Associated Colorectal Cancer
Ruiqi Sun, Yuanyuan Zhang, Xian Zhao, et al.
Advanced Science (2025)
Open Access
Joint exposure to multiple air pollutants and residual cardiovascular risk in hypertension
Yalan Li, Wei Hong, Jingjing Wu, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 291, pp. 117782-117782
Closed Access
Protocatechuic Acid Attenuates Inflammation in Macrophage-like Vascular Smooth Muscle Cells in ApoE−/− Mice
S. Li, Yushi Du, Guanyu Chen, et al.
Nutrients (2025) Vol. 17, Iss. 6, pp. 1090-1090
Open Access
Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction
Ana M. Briones, Raquel Hernanz, Ana B. García‐Redondo, et al.
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 5
Open Access
Remnant cholesterol predicts risk of recurrent thrombosis beyond LDL-cholesterol in patients with antiphospholipid syndrome
Bin Cai, Yangzhong Zhou, Xinzhuang Yang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Icosapent ethyl in cardiovascular prevention: Resolution of inflammation through the eicosapentaenoic acid - resolvin E1 - ChemR23 axis
Magnus Bäck
Pharmacology & Therapeutics (2023) Vol. 247, pp. 108439-108439
Open Access | Times Cited: 10
Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux
Sijin Chen, Wenli Zhang, Chun Tang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
The comparative study of the efficacy of recombinant human brain natriuretic peptide combined with vasoactive medications for elderly patients with heart failure and hypotension receiving injections
Rui Meng, Xiangnan Li, Huimin Liu, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Assessing Omega-3 Therapy and Its Cardiovascular Benefits: What About Icosapent Ethyl? A Systematic Review and Meta-Analysis
Nathália Mendes Machado, Maria Júlia Ribeiro de Oliveira, Karina Quesada, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 601-601
Open Access
Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators
Nusrath Yasmeen, Harikrishnan Selvaraj, Sudarshan Singh Lakhawat, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115437-115437
Open Access | Times Cited: 9
Differentiating EPA from EPA/DHA in cardiovascular risk reduction
Peter P. Tóth, M. John Chapman, Klaus G. Parhofer, et al.
American Heart Journal Plus Cardiology Research and Practice (2022) Vol. 17, pp. 100148-100148
Open Access | Times Cited: 14
Triglyceride levels and risk of cardiovascular disease and all-cause mortality in Chinese adults younger than 40 years old: a prospective cohort study
Zhaogui Wu, Jingli Gao, Shuohua Chen, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 2, pp. 240-250
Open Access | Times Cited: 2
Clinical results and mechanism of action of icosapent ethyl
Claudio Borghi, Alessio Bragagni
European Heart Journal Supplements (2023) Vol. 25, Iss. Supplement_B, pp. B37-B40
Open Access | Times Cited: 6
New Insights into Cardiovascular Diseases Treatment Based on Molecular Targets
Armanda Wojtasińska, Joanna Kućmierz, Julita Tokarek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16735-16735
Open Access | Times Cited: 6
Proliferative Vasculopathy Associated With Antiphospholipid Antibodies in Patients With Neurological Symptoms
Jina Yeo, Inpyeong Hwang, Chul‐Ho Sohn, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
A case control study on the relationship between occupational stress and genetic polymorphism and dyslipidemia in coal miners
Yongzhong Yang, Ziwei Zheng, Yuanyu Chen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Young hearts at risk: Unveiling novel factors in myocardial infarction susceptibility and prevention
Ashis Ranjan, Rajat Agarwal, Shiv Kumar Mudgal, et al.
Journal of Family Medicine and Primary Care (2024) Vol. 13, Iss. 4, pp. 1200-1205
Open Access | Times Cited: 1
Influence of multiple risk factor control level on cardiovascular outcomes in hypertensive patients
Xinyi Peng, Miaomiao Zhuang, Qirui Song, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top